HEADER SIGNALING PROTEIN 22-NOV-19 6TIA TITLE IRAK4 IN COMPLEX WITH INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: IRAK-4,RENAL CARCINOMA ANTIGEN NY-REN-64; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: IRAK4; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS IRAK4, KINASE, INHIBITOR, CANCER, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR Y.XUE,A.AAGAARD,S.L.DEGORCE REVDAT 3 01-MAY-24 6TIA 1 REMARK REVDAT 2 04-NOV-20 6TIA 1 JRNL REVDAT 1 28-OCT-20 6TIA 0 JRNL AUTH S.L.DEGORCE,A.AAGAARD,R.ANJUM,I.A.CUMMING,C.R.DIENE, JRNL AUTH 2 C.FALLAN,T.JOHNSON,K.J.LEUCHOWIUS,A.L.ORTON,S.PEARSON, JRNL AUTH 3 G.R.ROBB,A.ROSEN,G.B.SCARFE,J.S.SCOTT,J.M.SMITH,O.R.STEWARD, JRNL AUTH 4 I.TERSTIEGE,M.J.TUCKER,P.TURNER,S.D.WILKINSON,G.L.WRIGLEY, JRNL AUTH 5 Y.XUE JRNL TITL IMPROVING METABOLIC STABILITY AND REMOVING ALDEHYDE OXIDASE JRNL TITL 2 LIABILITY IN A 5-AZAQUINAZOLINE SERIES OF IRAK4 INHIBITORS. JRNL REF BIOORG.MED.CHEM. V. 28 15815 2020 JRNL REFN ESSN 1464-3391 JRNL PMID 33091850 JRNL DOI 10.1016/J.BMC.2020.115815 REMARK 2 REMARK 2 RESOLUTION. 2.52 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.52 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 76.33 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.7 REMARK 3 NUMBER OF REFLECTIONS : 23497 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.218 REMARK 3 R VALUE (WORKING SET) : 0.216 REMARK 3 FREE R VALUE : 0.261 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.950 REMARK 3 FREE R VALUE TEST SET COUNT : 1164 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 50 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.52 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.53 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.16 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 470 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2714 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 440 REMARK 3 BIN R VALUE (WORKING SET) : 0.2669 REMARK 3 BIN FREE R VALUE : 0.3399 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 6.38 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 30 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4529 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 340 REMARK 3 SOLVENT ATOMS : 195 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 76.21 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 75.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.59540 REMARK 3 B22 (A**2) : 13.14120 REMARK 3 B33 (A**2) : -14.73650 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.370 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.839 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.313 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.693 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.311 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.934 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.901 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4993 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6792 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1702 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 823 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4993 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 606 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5660 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.23 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.71 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 20.53 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: PLEASE NOTE THAT INH C1 & INH C2 ARE REMARK 3 THE TWO BOUND IN THE RESPECTIVE ATP POCKETS. THE REST OF LIGAND REMARK 3 MODELS (INH C3 TO C10) WERE BUILT TO ACCOUNT FOR THE RESIDUAL REMARK 3 ELECTRON DENSITY OUTSIDE OF THE PROTEIN, INTERPRETED AS BEING REMARK 3 INVOLVED IN THE PACKING INTERACTIONS IN THE CRYSTAL (AS STACKING REMARK 3 LAYERS BETWEEN PROTEIN MOLECULES). REMARK 4 REMARK 4 6TIA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 22-NOV-19. REMARK 100 THE DEPOSITION ID IS D_1292105528. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-JUL-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID30B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.976 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.21 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23542 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.520 REMARK 200 RESOLUTION RANGE LOW (A) : 76.330 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.7 REMARK 200 DATA REDUNDANCY : 6.300 REMARK 200 R MERGE (I) : 0.07900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.52 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.65 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.40 REMARK 200 R MERGE FOR SHELL (I) : 0.74300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: INTERNAL STARTING MODEL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.39 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.58 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.7 M AMS 0.1 M HEPES PH 7.1-7.7 REMARK 280 PROTEIN BUFFER: 50MM HEPES PH 7.5, 300 MM NACL, 0,02% OG, 1 MM REMARK 280 TCEP, 10% GLYCEROL, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 45.45000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 70.28500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 45.45000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 70.28500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 153 REMARK 465 GLU A 154 REMARK 465 ASN A 155 REMARK 465 LYS A 156 REMARK 465 SER A 157 REMARK 465 LEU A 158 REMARK 465 GLU A 159 REMARK 465 VAL A 160 REMARK 465 SER A 161 REMARK 465 ASP A 162 REMARK 465 MET A 218 REMARK 465 VAL A 219 REMARK 465 ASP A 220 REMARK 465 GLU A 337 REMARK 465 LYS A 338 REMARK 465 PHE A 339 REMARK 465 ALA A 340 REMARK 465 GLN A 341 REMARK 465 THR A 342 REMARK 465 SER A 460 REMARK 465 GLY B 153 REMARK 465 GLU B 154 REMARK 465 ASN B 155 REMARK 465 LYS B 156 REMARK 465 SER B 157 REMARK 465 LEU B 158 REMARK 465 GLU B 159 REMARK 465 VAL B 160 REMARK 465 SER B 161 REMARK 465 ASP B 162 REMARK 465 THR B 163 REMARK 465 MET B 218 REMARK 465 VAL B 219 REMARK 465 ASP B 220 REMARK 465 GLU B 337 REMARK 465 LYS B 338 REMARK 465 PHE B 339 REMARK 465 ALA B 340 REMARK 465 GLN B 341 REMARK 465 THR B 342 REMARK 465 SER B 460 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 181 102.15 -56.97 REMARK 500 GLU A 182 1.18 -68.49 REMARK 500 ASP A 254 -164.96 29.95 REMARK 500 ASP A 311 46.28 -151.62 REMARK 500 PHE A 323 32.93 71.75 REMARK 500 ASP A 329 87.78 56.13 REMARK 500 HIS A 390 48.57 -95.32 REMARK 500 LYS A 417 39.82 -87.91 REMARK 500 THR A 458 58.76 -95.69 REMARK 500 ASP B 181 102.37 -58.55 REMARK 500 GLU B 182 2.70 -69.98 REMARK 500 ASN B 206 -102.73 56.31 REMARK 500 THR B 222 -132.11 -85.77 REMARK 500 THR B 223 -44.11 -138.80 REMARK 500 GLU B 224 38.17 -89.30 REMARK 500 GLU B 225 -41.19 -143.10 REMARK 500 ASP B 311 48.37 -151.79 REMARK 500 ASP B 329 87.30 56.34 REMARK 500 HIS B 390 49.65 -95.56 REMARK 500 LYS B 417 35.43 -87.65 REMARK 500 THR B 458 60.02 -108.49 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ND2 A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ND2 A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ND2 A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ND2 A 504 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ND2 A 505 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ND2 B 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ND2 B 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ND2 B 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ND2 B 504 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ND2 B 505 DBREF 6TIA A 154 460 UNP Q9NWZ3 IRAK4_HUMAN 30 336 DBREF 6TIA B 154 460 UNP Q9NWZ3 IRAK4_HUMAN 30 336 SEQADV 6TIA GLY A 153 UNP Q9NWZ3 EXPRESSION TAG SEQADV 6TIA GLY B 153 UNP Q9NWZ3 EXPRESSION TAG SEQRES 1 A 308 GLY GLU ASN LYS SER LEU GLU VAL SER ASP THR ARG PHE SEQRES 2 A 308 HIS SER PHE SER PHE TYR GLU LEU LYS ASN VAL THR ASN SEQRES 3 A 308 ASN PHE ASP GLU ARG PRO ILE SER VAL GLY GLY ASN LYS SEQRES 4 A 308 MET GLY GLU GLY GLY PHE GLY VAL VAL TYR LYS GLY TYR SEQRES 5 A 308 VAL ASN ASN THR THR VAL ALA VAL LYS LYS LEU ALA ALA SEQRES 6 A 308 MET VAL ASP ILE THR THR GLU GLU LEU LYS GLN GLN PHE SEQRES 7 A 308 ASP GLN GLU ILE LYS VAL MET ALA LYS CYS GLN HIS GLU SEQRES 8 A 308 ASN LEU VAL GLU LEU LEU GLY PHE SER SER ASP GLY ASP SEQRES 9 A 308 ASP LEU CYS LEU VAL TYR VAL TYR MET PRO ASN GLY SER SEQRES 10 A 308 LEU LEU ASP ARG LEU SER CYS LEU ASP GLY THR PRO PRO SEQRES 11 A 308 LEU SER TRP HIS MET ARG CYS LYS ILE ALA GLN GLY ALA SEQRES 12 A 308 ALA ASN GLY ILE ASN PHE LEU HIS GLU ASN HIS HIS ILE SEQRES 13 A 308 HIS ARG ASP ILE LYS SER ALA ASN ILE LEU LEU ASP GLU SEQRES 14 A 308 ALA PHE THR ALA LYS ILE SER ASP PHE GLY LEU ALA ARG SEQRES 15 A 308 ALA SER GLU LYS PHE ALA GLN THR VAL MET TPO SEP ARG SEQRES 16 A 308 ILE VAL GLY THR THR ALA TYR MET ALA PRO GLU ALA LEU SEQRES 17 A 308 ARG GLY GLU ILE THR PRO LYS SER ASP ILE TYR SER PHE SEQRES 18 A 308 GLY VAL VAL LEU LEU GLU ILE ILE THR GLY LEU PRO ALA SEQRES 19 A 308 VAL ASP GLU HIS ARG GLU PRO GLN LEU LEU LEU ASP ILE SEQRES 20 A 308 LYS GLU GLU ILE GLU ASP GLU GLU LYS THR ILE GLU ASP SEQRES 21 A 308 TYR ILE ASP LYS LYS MET ASN ASP ALA ASP SER THR SER SEQRES 22 A 308 VAL GLU ALA MET TYR SER VAL ALA SER GLN CYS LEU HIS SEQRES 23 A 308 GLU LYS LYS ASN LYS ARG PRO ASP ILE LYS LYS VAL GLN SEQRES 24 A 308 GLN LEU LEU GLN GLU MET THR ALA SER SEQRES 1 B 308 GLY GLU ASN LYS SER LEU GLU VAL SER ASP THR ARG PHE SEQRES 2 B 308 HIS SER PHE SER PHE TYR GLU LEU LYS ASN VAL THR ASN SEQRES 3 B 308 ASN PHE ASP GLU ARG PRO ILE SER VAL GLY GLY ASN LYS SEQRES 4 B 308 MET GLY GLU GLY GLY PHE GLY VAL VAL TYR LYS GLY TYR SEQRES 5 B 308 VAL ASN ASN THR THR VAL ALA VAL LYS LYS LEU ALA ALA SEQRES 6 B 308 MET VAL ASP ILE THR THR GLU GLU LEU LYS GLN GLN PHE SEQRES 7 B 308 ASP GLN GLU ILE LYS VAL MET ALA LYS CYS GLN HIS GLU SEQRES 8 B 308 ASN LEU VAL GLU LEU LEU GLY PHE SER SER ASP GLY ASP SEQRES 9 B 308 ASP LEU CYS LEU VAL TYR VAL TYR MET PRO ASN GLY SER SEQRES 10 B 308 LEU LEU ASP ARG LEU SER CYS LEU ASP GLY THR PRO PRO SEQRES 11 B 308 LEU SER TRP HIS MET ARG CYS LYS ILE ALA GLN GLY ALA SEQRES 12 B 308 ALA ASN GLY ILE ASN PHE LEU HIS GLU ASN HIS HIS ILE SEQRES 13 B 308 HIS ARG ASP ILE LYS SER ALA ASN ILE LEU LEU ASP GLU SEQRES 14 B 308 ALA PHE THR ALA LYS ILE SER ASP PHE GLY LEU ALA ARG SEQRES 15 B 308 ALA SER GLU LYS PHE ALA GLN THR VAL MET TPO SEP ARG SEQRES 16 B 308 ILE VAL GLY THR THR ALA TYR MET ALA PRO GLU ALA LEU SEQRES 17 B 308 ARG GLY GLU ILE THR PRO LYS SER ASP ILE TYR SER PHE SEQRES 18 B 308 GLY VAL VAL LEU LEU GLU ILE ILE THR GLY LEU PRO ALA SEQRES 19 B 308 VAL ASP GLU HIS ARG GLU PRO GLN LEU LEU LEU ASP ILE SEQRES 20 B 308 LYS GLU GLU ILE GLU ASP GLU GLU LYS THR ILE GLU ASP SEQRES 21 B 308 TYR ILE ASP LYS LYS MET ASN ASP ALA ASP SER THR SER SEQRES 22 B 308 VAL GLU ALA MET TYR SER VAL ALA SER GLN CYS LEU HIS SEQRES 23 B 308 GLU LYS LYS ASN LYS ARG PRO ASP ILE LYS LYS VAL GLN SEQRES 24 B 308 GLN LEU LEU GLN GLU MET THR ALA SER MODRES 6TIA TPO A 345 THR MODIFIED RESIDUE MODRES 6TIA SEP A 346 SER MODIFIED RESIDUE MODRES 6TIA TPO B 345 THR MODIFIED RESIDUE MODRES 6TIA SEP B 346 SER MODIFIED RESIDUE HET TPO A 345 11 HET SEP A 346 10 HET TPO B 345 11 HET SEP B 346 10 HET ND2 A 501 34 HET ND2 A 502 34 HET ND2 A 503 34 HET ND2 A 504 34 HET ND2 A 505 34 HET ND2 B 501 34 HET ND2 B 502 34 HET ND2 B 503 34 HET ND2 B 504 34 HET ND2 B 505 34 HETNAM TPO PHOSPHOTHREONINE HETNAM SEP PHOSPHOSERINE HETNAM ND2 4-(1-METHYLCYCLOPROPYL)OXY-~{N}-[1-(1-METHYLPIPERIDIN- HETNAM 2 ND2 4-YL)PYRAZOL-4-YL]-6-(1-METHYLPYRAZOL-4-YL)PYRIDO[3,2- HETNAM 3 ND2 D]PYRIMIDIN-2-AMINE HETSYN TPO PHOSPHONOTHREONINE HETSYN SEP PHOSPHONOSERINE FORMUL 1 TPO 2(C4 H10 N O6 P) FORMUL 1 SEP 2(C3 H8 N O6 P) FORMUL 3 ND2 10(C24 H29 N9 O) FORMUL 13 HOH *195(H2 O) HELIX 1 AA1 SER A 169 ASN A 175 1 7 HELIX 2 AA2 THR A 222 CYS A 240 1 19 HELIX 3 AA3 SER A 269 CYS A 276 1 8 HELIX 4 AA4 LEU A 277 THR A 280 5 4 HELIX 5 AA5 SER A 284 ASN A 305 1 22 HELIX 6 AA6 THR A 351 MET A 355 5 5 HELIX 7 AA7 ALA A 356 ARG A 361 1 6 HELIX 8 AA8 THR A 365 GLY A 383 1 19 HELIX 9 AA9 LEU A 395 LEU A 397 5 3 HELIX 10 AB1 ASP A 398 ASP A 405 1 8 HELIX 11 AB2 THR A 409 ILE A 414 1 6 HELIX 12 AB3 ASP A 422 LEU A 437 1 16 HELIX 13 AB4 LYS A 440 ARG A 444 5 5 HELIX 14 AB5 ASP A 446 THR A 458 1 13 HELIX 15 AB6 SER B 169 THR B 177 1 9 HELIX 16 AB7 GLU B 225 CYS B 240 1 16 HELIX 17 AB8 SER B 269 CYS B 276 1 8 HELIX 18 AB9 LEU B 277 THR B 280 5 4 HELIX 19 AC1 SER B 284 ASN B 305 1 22 HELIX 20 AC2 LYS B 313 ALA B 315 5 3 HELIX 21 AC3 THR B 351 MET B 355 5 5 HELIX 22 AC4 ALA B 356 ARG B 361 1 6 HELIX 23 AC5 THR B 365 GLY B 383 1 19 HELIX 24 AC6 LEU B 395 LEU B 397 5 3 HELIX 25 AC7 ASP B 398 ASP B 405 1 8 HELIX 26 AC8 THR B 409 ILE B 414 1 6 HELIX 27 AC9 ASP B 422 LEU B 437 1 16 HELIX 28 AD1 LYS B 440 ARG B 444 5 5 HELIX 29 AD2 ASP B 446 MET B 457 1 12 SHEET 1 AA1 6 HIS A 166 SER A 167 0 SHEET 2 AA1 6 LEU A 248 SER A 252 1 O LEU A 249 N HIS A 166 SHEET 3 AA1 6 CYS A 259 VAL A 263 -1 O VAL A 261 N LEU A 249 SHEET 4 AA1 6 THR A 208 LYS A 214 -1 N LYS A 213 O LEU A 260 SHEET 5 AA1 6 VAL A 199 VAL A 205 -1 N TYR A 201 O VAL A 212 SHEET 6 AA1 6 LYS A 191 GLU A 194 -1 N MET A 192 O VAL A 200 SHEET 1 AA2 2 HIS A 307 ILE A 308 0 SHEET 2 AA2 2 ARG A 334 ALA A 335 -1 O ARG A 334 N ILE A 308 SHEET 1 AA3 2 ILE A 317 LEU A 319 0 SHEET 2 AA3 2 ALA A 325 ILE A 327 -1 O LYS A 326 N LEU A 318 SHEET 1 AA4 6 HIS B 166 SER B 167 0 SHEET 2 AA4 6 LEU B 248 SER B 253 1 O LEU B 249 N HIS B 166 SHEET 3 AA4 6 LEU B 258 VAL B 263 -1 O VAL B 261 N GLY B 250 SHEET 4 AA4 6 THR B 208 LEU B 215 -1 N LYS B 213 O LEU B 260 SHEET 5 AA4 6 GLY B 198 VAL B 205 -1 N TYR B 201 O VAL B 212 SHEET 6 AA4 6 LYS B 191 GLU B 194 -1 N MET B 192 O VAL B 200 SHEET 1 AA5 2 HIS B 307 ILE B 308 0 SHEET 2 AA5 2 ARG B 334 ALA B 335 -1 O ARG B 334 N ILE B 308 SHEET 1 AA6 2 ILE B 317 LEU B 319 0 SHEET 2 AA6 2 ALA B 325 ILE B 327 -1 O LYS B 326 N LEU B 318 LINK C MET A 344 N TPO A 345 1555 1555 1.35 LINK C TPO A 345 N SEP A 346 1555 1555 1.34 LINK C SEP A 346 N ARG A 347 1555 1555 1.35 LINK C MET B 344 N TPO B 345 1555 1555 1.34 LINK C TPO B 345 N SEP B 346 1555 1555 1.34 LINK C SEP B 346 N ARG B 347 1555 1555 1.36 CISPEP 1 GLY A 195 GLY A 196 0 -1.22 CISPEP 2 GLY A 196 PHE A 197 0 -5.32 CISPEP 3 GLU A 392 PRO A 393 0 2.46 CISPEP 4 GLY B 196 PHE B 197 0 -3.91 CISPEP 5 GLU B 392 PRO B 393 0 2.43 SITE 1 AC1 14 MET A 192 GLY A 193 VAL A 200 ALA A 211 SITE 2 AC1 14 TYR A 262 VAL A 263 TYR A 264 MET A 265 SITE 3 AC1 14 PRO A 266 GLY A 268 ASP A 278 THR A 280 SITE 4 AC1 14 LEU A 318 SER A 328 SITE 1 AC2 7 PHE A 230 ASP A 231 LYS A 235 ALA A 238 SITE 2 AC2 7 PHE A 251 SER A 253 ND2 A 503 SITE 1 AC3 2 ND2 A 502 ND2 A 504 SITE 1 AC4 3 ASN A 206 ND2 A 503 ND2 A 505 SITE 1 AC5 2 ND2 A 504 ND2 B 505 SITE 1 AC6 15 MET B 192 GLY B 193 ALA B 211 TYR B 262 SITE 2 AC6 15 VAL B 263 TYR B 264 MET B 265 PRO B 266 SITE 3 AC6 15 GLY B 268 ARG B 273 THR B 280 LEU B 318 SITE 4 AC6 15 SER B 328 HOH B 625 HOH B 648 SITE 1 AC7 9 LYS B 227 PHE B 230 ASP B 231 ILE B 234 SITE 2 AC7 9 LYS B 235 ALA B 238 PHE B 251 SER B 253 SITE 3 AC7 9 ND2 B 503 SITE 1 AC8 2 ND2 B 502 ND2 B 504 SITE 1 AC9 3 ASN A 175 ND2 B 503 ND2 B 505 SITE 1 AD1 6 GLU A 172 TYR A 204 ASN A 206 ASN A 207 SITE 2 AD1 6 ND2 A 505 ND2 B 504 CRYST1 90.900 140.570 56.020 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011001 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007114 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017851 0.00000